Keywords: peg-intron, malignant, melanoma, enzon, says, schering-plough, advanced

PEG-Intron A in Malignant Melanoma

Article | 01 October 1998

Print This

Enzon says that Schering-Plough has advanced PEG-Intron A, itslong-acting formulation of S-P's Intron A (interferon alfa-2b) into Phase III ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in